Taratingan, John .

HRN: 24-45-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/08/2025
02/14/2025
PO
3ml
Q12h
Pcap C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: